Primary angioplasty in patients ≥75 years old with ST-elevation myocardial infarction - One-year follow-up results

Kardiologia Polska

Volumn 66, Issue 8, 2008, Pages 828-833

  Ciszewski, Andrzej ^a   Karcz, Maciej ^a   Kȩpka, Cezary ^a   Bekta, Paweł ^a   Ksiȩzycka, Ewa ^a   Przyłuski, Jakub ^a   Dȩbski, Artur ^a   Witkowski, Adam ^a   Ruzyłło, Witold ^a  

^a INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

Elderly patients; Primary angioplasty; Prognosis; STEMI

Indexed keywords

ADULT; AGED; ARTICLE; BLEEDING; CONTROLLED STUDY; DIABETIC PATIENT; FEMALE; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART RATE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; ST SEGMENT ELEVATION; STROKE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

EID: 54049098332     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Rosengren A, Spetz CL, Köstner M, et al. Sex differences in survival after myocardial infarction in Sweden; data from the Swedish National Acute Myocardial Infarction Register. Eur Heart J 2001; 22: 314-22.
2. Fibrynolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomized trials of more then 1000 patients. Lancet 1994; 343: 311-22.
3. Gurwitz JH, Col NF, Avorn J. The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA 1992; 268: 1417-22.
4. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomized clinical trials. Lancet 2003; 361: 13-20.
5. The GUSTO Investigators. An international randomized trial comparing four thrombolitic strategies for acute myocardial infarction. N Engl J Med 1993; 329: 673-82.
6. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group. ISIS-3: a randomized comparison of streptokinase vs tissue plasminogen activator vs anistreplase and aspirin plus heparin vs aspirin alone among 41,299 cases of suspected myocardial infarction. Lancet 1992; 339: 753-70.
7. Grines CL, Brown KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. New Engl J Med 1993; 328: 673-9.
8. Polewczyk A, Janion M, Ga̧sior M, et al. Myocardial infarction in the elderly. Clinical and therapeutic differences. Kardiol Pol 2008; 66: 166-72.
9. Zielińska M, Bolińska H, Kaczmarek K, et al. Primary coronary angioplasty in the elderly. Kardiol Pol 2004; 60: 95-9.
10. Mehta RH, Sadiq I, Goldberg RJ, et al. Effectiveness of primary percutaneous coronary intervention compared with that of thrombolytic therapy in elderly patients with acute myocardial infarction. Am Heart J 2004; 147: 253-9.
11. de Boer MJ, Ottervanger JP, van't Hof AW, et al. Reperfusion therapy in elderly patients with acute myocardial infarction: a randomized comparison of primary angioplasty and thrombolytic therapy. J Am Coll Cardiol 2002; 39: 1723-8.
12. Thiemann DR, Coresh J, Schulman SP, et al. Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years. Circulation 2000; 101: 2239-46.
13. Karcz M, Kȩpka C, Bekta P, et al. Wyniki zabiegowego leczenia pacjentów z ostrym zawałem serca lub ostrym zespołem wieńcowym bez uniesienia odcinka ST - podsumowanie pierwszego roku całodobowego dyżuru kardiologii interwencyjnej w Instytucie Kardiologii w Warszawie-Aninie. Kardiol Pol 2003; 58 (IV): 36-43.
14. Kalinczuk Ł, Przyluski J, Karcz M, et al. Comparison of prognostic value of epicardial blood flow and early ST - segment resolution after primary angioplasty. ANIN - Myocardial Infarction Registry. Kardiol Pol 2007; 65: 1-10.
15. Karcz M, Bekta P, Kepka C, et al. Acute myocardial infarction complicated by cardiogenic shock. In-hospital and mid-term results of invasive treatment in the National Institute of Cardiology, Warsaw-Anin. Kardiol Pol 2003; 58: 366-9.
16. Gilum RF. Trends in acute myocardial infarction and coronary heart disease death in the United States. J Am Coll Cardiol 1994; 23: 1273-7.
17. Rich MW. Treatment of acute myocardial infarction. Am J Geriatr Cardiol 2001; 10: 328-36.
18. Guagliumi G, Stone GW, Cox DA, et al. Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction: results from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. Circulation 2004; 110: 1598-604.
19. Hochman JS, Tamis JE, Thompson TD, et al. Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators. N Engl J Med 1999; 341: 226-32.
20. Zalewski J, Żmudka K. Interwencyjne leczenie ostrych zespołów wieńcowych u pacjentów w wieku podeszłym. Kardiol Pol 2008; 66: 173-4.
21. Tiefenbrunn AJ, Chandra NC, French WJ, et al. Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol 1998; 31: 124-5.
22. Hands ME, Rutherford JD, Muller JE, et al. The in-hospital development of cardiogenic shock after myocardial infarction: incidence, predictors of occurrence, outcome and prognostic factors. The MILIS Study Group. J Am Coll Cardiol 1989; 14: 40-6.